(MedPage Today) — The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk…
The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult patients with symptomatic tenosynovial…
A new American Medical Association (AMA) report found growing physician enthusiasm and interest around the use of artificial intelligence (AI)…
Bram Sable-Smith Fans of the Philadelphia Eagles are celebrating their team’s Super Bowl victory with a parade today. They beat…
(MedPage Today) — When Senator Bill Cassidy, MD (R-La.) — a physician, longtime advocate for healthcare policy, and potential swing…
Sonya Stokes, an emergency room physician in the San Francisco Bay Area, braces herself for a daily deluge of patients…
This is part two of a two-part special CDIO profile story. To read part one, click here. Building a digital…
Digital health tools are all the rage. Hospitals and health systems are proving them to be useful in treating all…
Reducing unnecessary and potentially harmful tests and treatment of geriatric patients may require ongoing interventions, according to new research published…
February 14, 2025 Article HTML Nothing sweeps us off our feet like a health policy valentine. Readers showed their love…